Related references
Note: Only part of the references are listed.The extracellular matrix and immunity: breaking the old barrier in cancer
Maulik Vyas et al.
TRENDS IN IMMUNOLOGY (2022)
Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma
Yiqing Zang et al.
Aging-US (2021)
Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion
Paul Loftus et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Sijin Cheng et al.
CELL (2021)
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Xiujie Sun et al.
NATURE (2021)
The Role of Decorin and Biglycan Signaling in Tumorigenesis
Valentina Diehl et al.
FRONTIERS IN ONCOLOGY (2021)
High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery
Jessica M. Zielinski et al.
FRONTIERS IN IMMUNOLOGY (2021)
Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
Priyanka Hirani et al.
FRONTIERS IN ONCOLOGY (2021)
Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling
Dimitra Manou et al.
SEMINARS IN CANCER BIOLOGY (2020)
Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan
Zehra Elgundi et al.
FRONTIERS IN ONCOLOGY (2020)
Pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver oligometastatic MSS/MMR proficient colorectal cancer (CRC).
Dustin A. Deming et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments.
Philip Emmerich et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation
Thomas N. Wight et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity
Athanasios Papadas et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
David H. Peng et al.
NATURE COMMUNICATIONS (2020)
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Juliane Winkler et al.
NATURE COMMUNICATIONS (2020)
Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment
Endika Prieto-Fernandez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
Rilan Bai et al.
BIOMARKER RESEARCH (2020)
Proteoglycans remodeling in cancer: Underlying molecular mechanisms
Achilleas D. Theocharis et al.
MATRIX BIOLOGY (2019)
Biglycan is a new high-affinity ligand for CD14 in macrophages
Heiko Roedig et al.
MATRIX BIOLOGY (2019)
Hyaluronan: molecular size-dependent signaling and biological functions in inflammation and cancer
Anastasia G. Tavianatou et al.
FEBS JOURNAL (2019)
Versican proteolysis predicts immune effector infiltration and post-transplant survival in myeloma
Binod Dhakal et al.
LEUKEMIA & LYMPHOMA (2019)
Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer
Sandeep Appunni et al.
CLINICA CHIMICA ACTA (2019)
Next-Generation Cancer Immunotherapy Targeting Glypican-3
Yasuhiro Shimizu et al.
FRONTIERS IN ONCOLOGY (2019)
The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients
Moshira Ezzat Saleh et al.
PLOS ONE (2019)
Proteoglycans and Immunobiology of Cancer-Therapeutic Implications
George Tzanakakis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Versican and Tumor-Associated Macrophages Promotes Tumor Progression and Metastasis in Canine and Murine Models of Breast Carcinoma
Diego Carlos dos Reis et al.
FRONTIERS IN ONCOLOGY (2019)
VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1
Oisun Jung et al.
JOURNAL OF CELL SCIENCE (2019)
Role of glypicans in regulation of the tumor microenvironment and cancer progression
Sukhneeraj P. Kaur et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition
Jennifer J. Huang et al.
ONCOGENE (2019)
Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth
Apostolos G. Pappas et al.
ONCOIMMUNOLOGY (2019)
Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy
Jithendra Kini Bailur et al.
JCI INSIGHT (2019)
Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma
Mailee Huynh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers
Oliver M. T. Pearce et al.
CANCER DISCOVERY (2018)
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
Kyohei Nakamura et al.
CANCER CELL (2018)
Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling
Panagiotis Bouris et al.
MATRIX BIOLOGY (2018)
Chondroitin Sulfate Proteoglycan 4 and its Potential As an Antibody immunotherapy Target across Different Tumor Types
Kristina M. Ilieva et al.
FRONTIERS IN IMMUNOLOGY (2018)
Proteoglycans-Biomarkers and Targets in Cancer Therapy
Dragana Nikitovic et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Muhammad Umair Mushtaq et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Molecular mechanisms involved in dendritic cell dysfunction in cancer
Michael Tang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology
Liliana Schaefer et al.
FEBS JOURNAL (2017)
Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
J-Y Guo et al.
ONCOGENE (2017)
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer
Chelsea Hope et al.
JOURNAL OF IMMUNOLOGY (2017)
Provisional matrix: A role for versican and hyaluronan
Thomas N. Wight
MATRIX BIOLOGY (2017)
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Sherif Abdelaziz Ibrahim et al.
MOLECULAR CANCER (2017)
Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma
Adi Binder Gallimidi et al.
PLOS ONE (2017)
Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes
Anurag Purushothaman et al.
ONCOTARGET (2017)
SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
Z. Zhang et al.
ONCOGENESIS (2017)
Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers
Chiara Poluzzi et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Extracellular matrix structure
Achilleas D. Theocharis et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Versican vs versikine: tolerance vs attack
Michael Schmitt
BLOOD (2016)
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment
Chelsea Hope et al.
BLOOD (2016)
Shed proteoglycans in tumor stroma
Zoi Piperigkou et al.
CELL AND TISSUE RESEARCH (2016)
Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis
Louise Tzung-Harn Hsieh et al.
MATRIX BIOLOGY (2016)
Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions
Maria A. Gubbiotti et al.
MATRIX BIOLOGY (2016)
Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis
Qiaoqiao Chu et al.
CELL DEATH & DISEASE (2016)
Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth
Roland El Ghazal et al.
NEOPLASIA (2016)
High-Throughput Characterization and New Insight into the Role of Tumor Associated Macrophages (TAMs) in Multiple Myeloma (MM)
Paula Arana et al.
BLOOD (2016)
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Renato V. Iozzo et al.
MATRIX BIOLOGY (2015)
Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells
Yuliang Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling
Michael Tang et al.
CELL REPORTS (2015)
Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+T-Lymphocyte Infiltration and Increased Patient Survival
Athanasios Karapetsas et al.
BIOMED RESEARCH INTERNATIONAL (2015)
TPL2 kinase regulates the inflammatory milieu of the myeloma niche
Chelsea Hope et al.
BLOOD (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Transcriptional Activation by NFkB Increases Perlecan/HSPG2 Expression in the Desmoplastic Prostate Tumor Microenvironment
Curtis R. Warren et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Lumican affects tumor cell functions, tumor-ECM interactions, angiogenesis and inflammatory response
Dragana Nikitovic et al.
MATRIX BIOLOGY (2014)
De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways
Jinyang Zeng-Brouwers et al.
MATRIX BIOLOGY (2014)
Versican and the control of inflammation
Thomas N. Wight et al.
MATRIX BIOLOGY (2014)
Syndecans as modulators and potential pharmacological targets in cancer progression
Despoina Barbouri et al.
FRONTIERS IN ONCOLOGY (2014)
Serglycin: at the crossroad of inflammation and malignancy
Angeliki Korpetinou et al.
FRONTIERS IN ONCOLOGY (2014)
Biological interplay between proteoglycans and their innate immune receptors in inflammation
Helena Frey et al.
FEBS JOURNAL (2013)
Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
Brent A. Hanks et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro
Dong Li et al.
PLOS ONE (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation
Liliana Schaefer et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration
Neveen Said et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
Alexandra Naba et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Overview of the Matrisome-An Inventory of Extracellular Matrix Constituents and Functions
Richard O. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
Neveen Said et al.
ONCOIMMUNOLOGY (2012)
Carcinoma origin dictates differential skewing of monocyte function
Marijn Bogels et al.
ONCOIMMUNOLOGY (2012)
Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-β on the cell surface
Jin-Sung Chung et al.
BLOOD (2011)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma
Antonis Skliris et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
A Role for Serglycin Proteoglycan in Mast Cell Apoptosis Induced by a Secretory Granule-mediated Pathway
Fabio Rabelo Melo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Serglycin Is a Major Proteoglycan in Polarized Human Endothelial Cells and Is Implicated in the Secretion of the Chemokine GROα/CXCL1
Astri J. Meen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Serglycin: A Structural and Functional Chameleon with Wide Impact on Immune Cells
Svein O. Kolset et al.
JOURNAL OF IMMUNOLOGY (2011)
Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21
Rosetta Merline et al.
SCIENCE SIGNALING (2011)
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zoeller
NATURE REVIEWS CANCER (2011)
Roles for the type III TGF-β receptor in human cancer
Catherine E. Gatza et al.
CELLULAR SIGNALLING (2010)
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
Achilleas D. Theocharis et al.
FEBS JOURNAL (2010)
Differential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis
Norihiko Takeda et al.
GENES & DEVELOPMENT (2010)
Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting
Philippe Kischel et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The extracellular matrix at a glance
Christian Frantz et al.
JOURNAL OF CELL SCIENCE (2010)
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis
Kristin Moreth et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer
Arko Gorter et al.
MODERN PATHOLOGY (2010)
DAMPening Inflammation by Modulating TLR Signalling
A. M. Piccinini et al.
MEDIATORS OF INFLAMMATION (2010)
Sterile inflammation: sensing and reacting to damage
Grace Y. Chen et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Ligation of TLR2 by Versican: A Link Between Inflammation and Metastasis
Wei Wang et al.
ARCHIVES OF MEDICAL RESEARCH (2009)
Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma
Hirotake Takai et al.
CANCER BIOLOGY & THERAPY (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses
Jin-Sung Chung et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
Andrea Babelova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity
Behzad Kharabi Masouleh et al.
JOURNAL OF IMMUNOLOGY (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
The type III TGF-β receptor regulates epithelial and cancer cell migration through β-arrestin2-mediated activation of Cdc42
Karthikeyan Mythreye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The matricellular functions of small leucine-rich proteoglycans (SLRPs)
Rosetta Merline et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Delayed contraction of the CD8+ T cell response toward lymphocytic choriomeningitis virus infection in mice lacking serglycin
Miriana Grujic et al.
JOURNAL OF IMMUNOLOGY (2008)
Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation
Jin-Sung Chung et al.
JOURNAL OF IMMUNOLOGY (2007)
Tumor-reactive CD4+ T cell responses to the melanoma-associated chondroitin sulphate proteoglycan in melanoma patients and healthy individuals in the absence of autoimmunity
Cornelia Erfurt et al.
JOURNAL OF IMMUNOLOGY (2007)
Shedding of syndecan-1 by stromal fibroblasts stimulates human breast cancer cell proliferation via FGF2 activation
Gui Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
DC-HIL is a negative regulator of T lymphocyte activation
Jin-Sung Chung et al.
BLOOD (2007)
Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells
Tiago Braga et al.
BIOCHEMICAL JOURNAL (2007)
Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-α secretion in response to lipopolysaccharide
Lillian Zernichow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells
Constance Y. Fears et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of syndecans in disease and wound healing
Constance Y. Fears et al.
MATRIX BIOLOGY (2006)
Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage
M Grujic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages
L Schaefer et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The interaction of versican with its binding partners
YJ Wu et al.
CELL RESEARCH (2005)
PKC- and PI3K-dependent but ERK-independent proliferation of murine splenic B cells stimulated by chondroitin sulfate B
E Aoyama et al.
IMMUNOLOGY LETTERS (2005)
Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling
N Vij et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Serglycin is essential for maturation of mast cell secretory granule
M Åbrink et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46
N Bloushtain et al.
JOURNAL OF IMMUNOLOGY (2004)
PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation
PS Zheng et al.
JOURNAL OF CELL SCIENCE (2004)
Distinct interaction of versican/PG-M with hyaluronan and link protein
K Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes
LJ Marshall et al.
JOURNAL OF IMMUNOLOGY (2003)
The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones
S Munesue et al.
BIOCHEMICAL JOURNAL (2002)
Betaglycan inhibits TGF-β signaling by preventing type I-type II receptor complex formation -: Glycosaminoglycan modifications alter betaglycan function
O Eickelberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of immature DC with upregulation of costimulatory and antigen-presenting molecules, and enhancement of NF-kappa B and protein kinase activity
R Yang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2002)
Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: Shed syndecan-1 accumulates in fibrotic regions
IB Bayer-Garner et al.
MODERN PATHOLOGY (2001)
Glypicans: proteoglycans with a surprise
J Filmus et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4
JD Sandy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Versican interacts with chemokines and modulates cellular responses
J Hirose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44
H Kawashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ
Z Chang et al.
FASEB JOURNAL (2000)
Share Paper
